Table of Contents



Indicators 3a
1) Number of IUDs distributed by PSI
2) Number of implants distributed by PSI




 

Indicator

3a-1

 
Number of IUDs distributed by PSI
 
Workplan:  X IUDs distributed by PSI by Dec. 2018
Indicator Type
Mandatory
Where Reported
Workplan, Tracker
Numerator
Total IUD sales + free distribution
Denominator
N/A
Purpose
To measure long term method availability in public and private sectors
 
Data Source
MIS
Data Collection Frequency
Monthly
Notes:
Guidance:
  • Free distribution must be less than 15% of the total distribution (sales plus free distribution).
  • Include only PSI commodities procured with Foundation funding. Do not include distribution of IUDs received from MOH, other donors or purchased with other donor funding – these should be coded and reported on the CTL under the appropriate source. Including other commodities under WHP will result in double counting.
Tracker:
  • Report data for IUD10 and IUD5 on separate rows on the tracker
  • Report IUDs distributed for free and those sold on separate rows
  • Report IUDs distributed  to  network providers and  non-network on separate rows
Workplan:Report the total number of IUDs distributed (free + sold) to ALL providers (network and non-network) under both “Total Project” and
“Period Achievement”

































 

Indicator

3a-2

 
Number of implants distributed by PSI
 
Workplan:  X implants distributed by PSI by Dec. 2018
Indicator Type
Optional   (MUST INCLUDE if country program includes WHP implants)
Where Reported
Workplan, Tracker
Numerator
Total implant sales + free distribution
Denominator
N/A
Purpose
To measure long term method availability in public and private sectors
 
Data Source
MIS
Data Collection Frequency
Monthly
Notes:
Guidance:
  • Free distribution must be less than 5% of the total distribution (free plus sold).
  • Once 100% Life of Project (LoP) projection has been achieved, additional implant distribution is not supported under WHP
  • Include only PSI commodities procured with Foundation funding. Do not include distribution of IUDs received from MOH, other donors or purchased with other donor funding – these should be coded and reported on the CTL under the appropriate source. Including other commodities under WHP will result in double counting.
Tracker:
  • Report  implants distributed for 1) free and 2) sold on separate rows
  • Report type of implant distributed on appropriate rows.
  • Do NOT report more than 100% LoP projection 
Workplan:
  • Report total implants distributed (free + sold) under both “Total Project” and “Period Achievement”